Introduction
Intimate partner violence (IPV) against women has been identified as a serious health problem and is a leading cause of non-fatal injury in females in North America (Kyriacou et al, 1999; Dannenberg et al, 1994) . Intimate partner violence is described by the American Medical Association as "a pattern of coercive behaviours that may include repeated battering and injury, psychological abuse, sexual assault, progressive social isolation, deprivation, and intimidation" (McCloskey et al, 2007) . These behaviours are perpetrated by someone who is in a private and personal relationship with another individual, such as a victim's spouse, common-law partner, sexual partner, or dating partner.
Some studies have reported that as high as 54 percent of all women have experienced some form of IPV during the course of their life (Reisenhofer et al, 2007) . Women who are victims of IPV have been known to utilize health care services at higher rates than women who have not been abused (Bhandari et al, 2006; Hazen et al, 2004) . They may present to a number of different medical specialists including emergency room physicians, orthopaedic or trauma surgeons, family physicians, and specialists in obstetrics and gynecology during routine appointments or for appointments specific to their injuries. Researchers and advocates have argued that health care providers can play a vital role in detecting IPV (Davidson et al, 2001 ).
Despite these recommendations for universal screening, the response from the medical community to address the issue of domestic violence has been characterized as "slow and inconsistent" (Davis, 2008) . Intimate partner violence is an under-recognized, recurrent part of trauma, present in at least one in five women who present to the Emergency Department, and physicians frequently fail to make this diagnosis (Davis, 2008) . The failure to detect IPV contributes to recidivism and long-term health problems (Glass et al, 2001 ). In addition, when injuries resulting from IPV are not recorded in medical records, abused women are denied documentation of their injuries for future references in court cases (Glass et al, 2001 ). Additionally, opportunities to provide education about prevention, lethality assessment, safety planning, and options for escaping an abusive situation and referrals to resources within the community may also be missed (Glass et al, 2001 ).
The reported rates of IPV vary across different subspecialties and may be underreported. While several studies have reported the prevalence rates of IPV in the health care setting, these estimates vary substantially. Best estimates of rates across various subspecialties are lacking. We therefore undertook a systematic review and meta-analysis of the published literature to determine the prevalence rates of IPV reported to different medical subspecialties including family medicine, emergency medicine, obstetrics and gynaecology, internal medicine, addiction recovery clinics, and adults with child patients in paediatric clinics. The study has important implications for healthcare professionals in various settings. It will direct attention to medical practitioners in subspecialties where IPV is overlooked and will impact their interaction with and treatment of IPV victims as well as victims' willingness to disclose. Also, identification of health care settings with the highest prevalence rates will allow targeted research and focus towards improvement of the quality of life of IPV victims.
Methods
This systematic review adheres to the reporting guidelines of the Meta-analysis Of Observational Studies in Epidemiology (MOOSE) Statement (Stroup et al, 2000) . 48 
Eligibility Criteria
We identified articles in all languages that met the following eligibility criteria: 1) the study was published between January 1995 and July 2009, 2) the target population consisted of adult women between the ages of 16 and 65 years presenting to physicians of any medical specialty, and 3) the primary objective of the study was to determine the prevalence rates of IPV. We included all study designs including cross-sectional designs, surveys, and chart or medical record reviews. We excluded studies focusing on children, males, and special populations such as pregnant women, elderly patients, and patients suffering from a specific illness (i.e. depression, chronic gastrolo-enterological disease). We also excluded review articles, letters, comments, case reports, and guidelines.
Identification of Studies
Two reviewers (C.H., S. dM.) independently conducted a search of the electronic database PubMed for relevant articles published from 1995 to July 2009 in all languages with the help of a professional librarian. Additional strategies used to identify studies included consultation with experts, a review of reference lists from articles that fulfilled our eligibility criteria, and use of the "related articles" feature in PubMed for all studies meeting our entry criteria.
Assessment of Study Eligibility
Two of the authors (C.H. S. dM.) independently assessed all studies identified for full evaluation and resolved disagreements through discussion towards consensus. The eligibility was verified by two additional authors (S.S., N.S.). Agreement between observers for study eligibility with regard to abstract and full text review was examined using the (kappa) statistic. The inter-observer agreement in methodological quality scores was evaluated using the intraclass correlation coefficient. We chose an a priori criterion of 95% confidence intervals were calculated using the generic formula: Estimate ± 1.96*(Standard Error).
Assessment of Methodological Quality
Two reviewers (N.S., S.S.), both with methodological expertise and one with content expertise (S.S.) independently graded the methodological quality of each included study using questions adapted from the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement designed for cross-sectional studies (von Elm et al, 2008 ) and we did not find that any of the previously developed checklists were appropriate for this study. Therefore, we adapted the STROBE statement to assess study quality. A priori we determined that studies that met at least 10 of the 49 13 reporting criteria within our modified STROBE criteria would be considered high quality, studies that met seven to nine reporting criteria would be considered medium quality, and studies that met six or fewer criteria would be classified as low quality.
Data Extraction
A structured data extraction form was developed and relevant data was extracted from each eligible study in duplicate (S.S., N.S.) to ensure accuracy. Pertinent data included study characteristics (year and location), patient characteristics (age), type of medical sub-speciality (emergency medicine, family medicine, obstetrics and gynaecology, internal medicine, addiction recovery, pediatrics, and public health), method of data collection (survey, interview, chart review, and other design), timeframe (lifetime, one-years, two-years, and other), sample size, and response rate. We documented how the authors defined IPV, physical, emotional, and sexual abuse. Finally, we recorded the reported rates of IPV, physical abuse, emotional, and sexual abuse as reported by the authors.
Data Analysis
We provide pooled rates of lifetime and one year physical abuse, emotional abuse, and sexual abuse for emergency medicine, family medicine, and other specialties. Analyses were performed with Predictive Analytics SoftWare (PASW) Statistics version 18.0 (SPSS Inc. Chicago, IL, USA).
Evaluation of Heterogeneity
Before analyzing the data, we hypothesized that there would be a large degree of heterogeneity between the studies. Differences such as study methodology (e.g. survey versus interview versus other study designs), timelines of reported IPV (e.g. lifetime versus one-year), differences in screening tools used (e.g. AAS, CTS, PVS etc.), variability within and between populations (e.g. socioeconomic status, age, jurisdiction), differences in the definition of IPV perpetrator (e.g. male perpetrator versus perpetrator of any gender, or spouse versus any intimate partner), or variable study quality could contribute to the heterogeneity.
Results

Study Identification
Our literature search identified 894 potentially relevant citations, of which 32 were considered for inclusion after full text review (Figure 1 ). Eighteen of these 32 studies were excluded after verification by additional reviewers (NS and SS) because of insufficient data on IPV prevalence, or they did not meet the eligibility criteria. Of 80 studies considered for inclusion based on review of bibliographies, 20 were included in this study. Three studies were identified and included after consultation with a content expert. In total, 37 studies were included in this review. The weighted kappa on overall agreement between reviewers when choosing articles for the full text review was 0.70 (95% confidence interval, 0.59 to 0.82), and for final study inclusion there was only one disagreement. 
Study Characteristics
Details of the selected studies are shown in Table 1 . The mean age of participants in the included studies was between 28 and 65 years, with 17 studies not reporting mean age. Response rates ranged from 9% to 100% with most studies (24/37 64.9%) reporting a response rate of 70% or greater. Twenty-five studies (67.6%) took place in the United States, three studies took place in each of Australia and the United Kingdom, and other locations (Canada, Spain, Iran, Israel, South Africa, and China) each have one study. Most studies took place in family medicine clinics (15/37, 40.5%) and emergency departments (12/37, 32.4%). Of the remaining studies, three took place in obstetrics and gynecology clinics, three took place in internal medicine clinics, and four studies had more than one specialty. Nineteen studies (51.4%) used written questionnaires to assess rates of IPV, fourteen studies (37.8%) used an inperson interview, one study (2.7%) used a telephone survey, one study (2.7%) used a computerbased survey, and two studies (5.4%) used more than one method.
Study Quality
We judged 26 studies to be of high methodological quality, 10 studies to be of moderate quality, and the remaining 1 study to be of low quality ( Table 1 ). The reviewers of methodological quality achieved moderate agreement (intraclass correlation coefficient, 0.65; 95% confidence interval, 0.57 to 0.71.
Definition of Intimate Partner Violence
The definition of intimate partner violence varied greatly between studies. The two most commonly used screening tools among included studies were the Abuse Assessment Screen (13 studies, 35.1%) and the Conflict Tactics Scale (5 studies, 13.5%), or modified versions of these tools. Many studies used gender-neutral language, such as "partner", but others specified that the abuser must be male (8 studies, 21.6%). Most studies included only female victims, but a small number (3 studies, 8.1%) also included male victims.
Intimate Partner Violence Prevalence
Twenty-nine of the included studies (78.4%) presented an overall rate of IPV. Overall pooled lifetime prevalence rates were similar across family medicine and emergency medicine (38% and 40%, respectively). Rates reported for other specialties, however, were considerably higher (59%). Prevalence rates of intimate partner violence in the past year were also similar across studies in family practice and emergency clinics (19.9% versus 19.5%, respectively) (Tables 2 and 3) . Between 2% and 4.3% of female patients presenting to emergency departments were reported to have injuries caused by a current or former intimate partner ( Table 2) . Based on a single study in each of pediatric emergency medicine and public health clinics, these specialties have lower rates of physical IPV than other specialties in the reviewed articles ( Table  4) . Please see Figure 2 for pooled prevalence rates of IPV across specialties. High *The quality score is based upon the STROBE Statement for cross-sectional studies. NR = not reported. 
Discussion
Our systematic review and meta-analysis found that the pooled prevalence rates of IPV in emergency medicine and family medicine are similar for both lifetime and one year timelines. Pediatric emergency medicine and public health clinics had lower rates of physical IPV than other specialties, although there were fewer studies in these specialties than others. Physical IPV was more commonly reported than both emotional IPV and sexual IPV, and the rates of sexual abuse tend to be lower than physical and emotional abuse, with emotional abuse being the most common type of IPV.
Several strengths contributed to the quality of this study. A comprehensive search of the literature as well as data abstraction from eligible studies was conducted by two independent reviewers to ensure accuracy, and the articles were screened thoroughly and systematically for inclusion criteria. There was a high degree of agreement between the two reviewers, and many studies of general high quality are included in the review. Also, the results can be highly generalized due to the broad eligibility criteria.
Despite these strengths, our study is limited by a large degree of heterogeneity across the included studies. Heterogeneity was likely a product of many factors including different methodology, populations, and definitions of IPV utilized across the eligible studies. The included studies had varying population characteristics and utilized a variety of different screening tools, which likely contributed to the wide variations in prevalence rates reported. Despite the large variations, our pooled data shows that the prevalence of IPV in emergency medicine and family medicine are similar. Another limitation is the moderately low intraclass correlation coefficient for agreement on methodological quality. This is likely due to the chance for greater variability with an extensive 13-item checklist.
The definition of IPV used is essential to compare studies of IPV prevalence. Differences in definitions include the timeline reported, screening tool used, type(s) of IPV included, and definition of perpetrator and victim. A total of nine different timelines were presented by included studies (lifetime, one year, acute, one month, three months, most recent relationship, current relationship, past relationship, and past five years). The included studies also used a variety of screening tools that have been validated to differing degrees, or adaptations of screening tools that have not undergone validation studies. Rabin et al (2009) reported that even the most commonly studied screening tools are only validated in a small number of studies. Since no "gold standard" exists to screen for IPV in a clinical setting, comparing results across screening tools is a challenge. These differences in definition make IPV a difficult subject to fully understand without some sort of standardization.
Despite similar definitions differences still occurred. There were three studies that used the AAS (the most common screening tool among included articles), similar definitions of physical IPV, and included a family medicine population (Kramer et al, 2004; Marais et al, 1999; Johnson D, 1997) . All three studies had sample sizes of over 1,000 patients, used a lifetime timeline and were considered moderate or high quality studies. However, Kramer et al (2004) found that the prevalence of physical IPV was far greater than the other two studies (over 50% vs. 14.6% and 13.9%). The population may account for this variation. In addition, the studies included in this review employed a variety of methods of data collection. MacMillan et al (2006) found that the prevalence of IPV depends on the type of administration (written, verbal, or computer-based) and there was an interaction between method of administration and screening tool used. Some studies suggest that computer-based screening can increase disclosure (Turner et al, 1998) , and others suggest that face-to-face interviews increase disclosure over written surveys (McFarlane et al, 1991) . One of the included studies used computer-based screening, and obtained an overall prevalence of 36.0% in the past year in emergency medicine (Houry et al, 2006) . This is the highest included prevalence for the one year timeline in emergency medicine. Results vary for written surveys versus in person interviews in this review.
We did not identify published studies on the prevalence of IPV across all subspecialties. There were no included studies in populations undergoing surgery, although surgeons likely encounter multiple patients who are victims of IPV. Orthopaedic and trauma surgeons, for example, may frequently treat victims of physical IPV in their practice (Bhandari, 2006 ), yet none of the included studies measured prevalence of IPV in orthopaedic clinics. A large multicentre cross-sectional prevalence study is presently underway that will investigate the prevalence of IPV in patients presenting to orthopaedic fracture clinics (PRAISE Investigators, 2010). None of the included studies reported the prevalence of IPV among psychiatric patients, which could be another high-risk population. It may be important to study other medical specialties, even those expected to identify lower rates of IPV, because victims of IPV do not readily disclose their history of abuse to health care providers (Spangaro et al, 2010 ).
In conclusion, prevalence rates have been reported in the literature for various medical specialties including family medicine, emergency medicine, and others. However, the studies show a great degree of heterogeneity and are, therefore, difficult to compare. It would be easier to compare prevalence rates across studies if the definition of IPV remained constant. Based on our pooled data, best estimates of IPV prevalence in emergency medicine and family medicine appear to be similar. Future studies could investigate the prevalence of IPV in other specialties, and should use similar definitions of IPV.
